Sinew Pharma (ROCO:6634) Total Liabilities : NT$29.61 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Total Liabilities?

Sinew Pharma's Total Liabilities for the quarter that ended in Jun. 2023 was NT$29.61 Mil.

Sinew Pharma's quarterly Total Liabilities increased from Jun. 2022 (NT$23.43 Mil) to Dec. 2022 (NT$28.66 Mil) and increased from Dec. 2022 (NT$28.66 Mil) to Jun. 2023 (NT$29.61 Mil).

Sinew Pharma's annual Total Liabilities declined from Dec. 2020 (NT$17.40 Mil) to Dec. 2021 (NT$15.96 Mil) but then increased from Dec. 2021 (NT$15.96 Mil) to Dec. 2022 (NT$28.66 Mil).

Sinew Pharma Total Liabilities Historical Data

The historical data trend for Sinew Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Total Liabilities Chart

Sinew Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

12.13

252.01

17.40

15.96

28.66

Sinew Pharma Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Liabilities	Get a 7-Day Free Trial												1,009.74	15.96	23.43	28.66	29.61

Sinew Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sinew Pharma's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	23.25	+	(4.558	+	0.85
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	28.66

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	1487.161	-	1458.503
	=	28.66

Sinew Pharma's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	21.806	+	(6.104	+	1.7
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	29.61

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	1439.545	-	1409.935
	=	29.61

Sinew Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinew Pharma (ROCO:6634) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571

Website

https://www.sinewpharma.com

Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines